Small companies like GHDX never get to make the big money,a bigger pharma/Co always comes in for the kill and the quick buck insiders and shareholders love. Would you take $65 tomorrow?,if not a majority would.
So true.The pieces of the company in R&D in laying out the international markets and science verification and a stock selling for 3 X revenues means the groundwork is being laid for a Baker Brothers sale.
Credit Suisse joined BAC and others all downgrading interestingly enough to "Neutral" No sells all in the mid 30s " and have attacked the stock. Volume taking down the stock 25% was very low meaning someone is buying the shares.Guess who.
Got out 20% ago. The call was 11% growth but guidance was on the lower side,but 20%? When promising bios are about to announce a merger a takeover they push the stock down as hard as possible.Bet you will soon see the Bakers newest SEC doc.accumulating.buying a lot.just hit below 36 wow!
Sold out most of my position at years end after consulting with the company.They do not plan for a sales pickup from the prostate trial for another 6-9 months as various world agencies have not officially sanctioned the test. Company continues to be barely profitable with a crazy PE.There is serious competition from other countries